| Combination therapy in combating cancer RB Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, B Das, ... Oncotarget 8 (23), 38022, 2017 | 1871 | 2017 |
| Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction B Das, R Tsuchida, D Malkin, G Koren, S Baruchel, H Yeger Stem cells 26 (7), 1818-1830, 2008 | 350 | 2008 |
| CD271+ bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis B Das, SS Kashino, I Pulu, D Kalita, V Swami, H Yeger, DW Felsher, ... Science translational medicine 5 (170), 170ra13-170ra13, 2013 | 228 | 2013 |
| A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1α through mitogen-activated protein kinase/extracellular signal … B Das, H Yeger, R Tsuchida, R Torkin, MFW Gee, PS Thorner, M Shibuya, ... Cancer research 65 (16), 7267-7275, 2005 | 174 | 2005 |
| Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid MFW Gee, R Tsuchida, C Eichler-Jonsson, B Das, S Baruchel, D Malkin Oncogene 24 (54), 8025-8037, 2005 | 124 | 2005 |
| In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity: implications in cancer chemotherapy B Das, H Yeger, H Baruchel, MH Freedman, G Koren, S Baruchel European Journal of Cancer 39 (17), 2556-2565, 2003 | 111 | 2003 |
| Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth B Das, R Antoon, R Tsuchida, S Lotfi, O Morozova, W Farhat, D Malkin, ... Neoplasia 10 (10), 1105-IN4, 2008 | 110 | 2008 |
| Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma L Zhang, H Yeger, B Das, MS Irwin, S Baruchel Neoplasia 9 (1), 36-46, 2007 | 100 | 2007 |
| Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling R Tsuchida, B Das, H Yeger, G Koren, M Shibuya, PS Thorner, ... Oncogene 27 (28), 3923-3934, 2008 | 94 | 2008 |
| HIF‐2α suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells B Das, R Bayat‐Mokhtari, M Tsui, S Lotfi, R Tsuchida, DW Felsher, ... Stem cells 30 (8), 1685-1695, 2012 | 89 | 2012 |
| MYC Regulates the HIF2α Stemness Pathway via Nanog and Sox2 to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells B Das, B Pal, R Bhuyan, H Li, A Sarma, S Gayan, J Talukdar, S Sandhya, ... Cancer research 79 (16), 4015-4025, 2019 | 83 | 2019 |
| A rare fraction of drug‐resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential CG Lee, B Das, TL Lin, C Grimes, X Zhang, T Lavezzi, L Huang, J Cole, ... British journal of haematology 158 (1), 79-90, 2012 | 67 | 2012 |
| Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1α F Forooghian, B Das American journal of ophthalmology 144 (5), 761-768, 2007 | 64 | 2007 |
| Preclinical and clinical evidence of Mycobacterium tuberculosis persistence in the hypoxic niche of bone marrow mesenchymal stem cells after therapy J Garhyan, S Bhuyan, I Pulu, D Kalita, B Das, R Bhatnagar The American journal of pathology 185 (7), 1924-1934, 2015 | 59 | 2015 |
| Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs DI Bellovin, B Das, DW Felsher Systems Biology of Tumor Dormancy, 91-107, 2013 | 57 | 2013 |
| BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors R Tsuchida, T Osawa, F Wang, R Nishii, B Das, S Tsuchida, M Muramatsu, ... Oncogene 33 (29), 3803-3811, 2014 | 56 | 2014 |
| In vitro Culture of Naïve Human Bone Marrow Mesenchymal Stem Cells: A Stemness Based Approach B Pal, B Das Frontiers in cell and developmental biology 5, 69, 2017 | 54 | 2017 |
| Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment G Beamer, S Major, B Das, A Campos-Neto The American journal of pathology 184 (12), 3170-3175, 2014 | 52 | 2014 |
| The oral mouse microbiome promotes tumorigenesis in oral squamous cell carcinoma P Stashenko, S Yost, Y Choi, T Danciu, T Chen, S Yoganathan, ... Msystems 4 (4), 10.1128/msystems. 00323-19, 2019 | 51 | 2019 |
| SBDS‐deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth C Ambekar, B Das, H Yeger, Y Dror Pediatric blood & cancer 55 (6), 1138-1144, 2010 | 50 | 2010 |
Herman YegerThe Hospital for Sick ChildrenVerified email at sickkids.ca
